
ABMD is an $825.7 million healthcare company that provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. ABMD has excellent volume trends and recently needed some relief from very overbought levels. There was also a long-term negative divergence that had printed and that led to a subsequent 50 day SMA test and a MACD “reset” at the centerline. The selling over the past four or five sessions helped to relieve the overbought issue and now sets up ABMD to be in a much more favorable reward to risk trade. We like entry at the current price and again at $21.15. We’d keep a tight closing stop beneath $20.98 and our initial target would be $24.18.
You should consider these educational charts and analysis for possible short-term trades only. We are not registered investment advisors and the following trade setups should not be viewed as investment advice. Accordingly, please check with your financial advisor before deciding to buy or sell any of these investment securities. Read our full Disclaimer below.
Because we do not recommend holding a stock into its earnings report, please check all earnings dates on Charts of the Day stocks before making a decision on whether to consider a trade.








